Apotex Health Corp (APTX.TO) has seen notable performance this week, driven by its recent developments.
This week, Apotex Health Corp experienced a price increase of 5.52%, closing at C$33.63 on Monday. This uptick comes against the backdrop of a series of positive announcements regarding the company's performance and strategic initiatives.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeMarket cap
$7.43B
52W high
$40.11
52W low
$26.01
1W change
+5.21%
Analyst Price Targets
Based on analyst covering APTX · as of Sep 23, 2026
Wall Street analysts forecast APTX stock price to rise 27.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.37
+27.3% Upside
Previously C$41.23 on Sep 17, 2026
Current Price
C$32.50
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
46.1%
Annualized
90-Day Vol
45.8%
Annualized
Trend (90d)
-32.2%
Annualized drift
90d Mean
C$29.62
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$31.98 | C$27.28 – C$37.49 |
| 60 trading days | C$30.77 | C$24.58 – C$38.54 |
| 90 trading days | C$29.62 | C$22.48 – C$39.01 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors may want to consider Apotex's recent growth metrics and strategic moves as it continues to establish itself in the market, despite a recent decline in its stock price over the past month.
C$33.63 Close with 5.52% Weekly Gain
Over the past month, Apotex's stock has declined by 10.32%, despite a year-to-date increase of 22.29%, reflecting volatility in the stock's performance.
Bull case
The company reported an 11% revenue growth in Canada and a strong adjusted EBITDA with a 31% margin in its latest quarterly results. This suggests solid operational performance and a positive outlook for future growth.
Bear case
Despite the recent positive news, Apotex has a negative profit margin of -0.9% and a declining stock price over the past month, which could indicate underlying challenges that investors should be aware of.
Recent Price Action
This week, Apotex Health Corp's stock rose by 5.52%, closing at C$33.63 on Monday, reflecting a 1.85% increase for the day. This upward trend is notable as it contrasts with a monthly decline of 10.32%. Year-to-date, the stock has appreciated by 22.29%, showcasing its potential for recovery.
Company News and Developments
Advertisement
While there were no major announcements this week, Apotex has been active in recent months. Notably, the company reported its first-quarter results for 2027 on August 12, 2026, showing an 11% revenue growth in Canada and an adjusted EBITDA of $259 million with a 31% margin. Additionally, the establishment of an investment-grade issuer rating and completion of a credit agreement in July indicates a strengthening financial position.
Technical Picture
From a technical perspective, Apotex is currently trading below its 50-day moving average of C$35.28 and its 200-day moving average of C$34.20, indicating potential resistance levels. The stock's 52-week range has been between C$26.05 and C$40.18, with the current price at approximately 54% of this range. The recent trading volume of 242,930 shares is below the 20-day average of 284,662 shares, suggesting decreased trading activity.
Insider Activity
No recent insider activity has been reported for Apotex Health Corp, which may indicate a stable insider sentiment towards the company's current direction.
Price Action Summary
As of the latest close, Apotex Health Corp's stock is at C$33.63, marking a 1D gain of 1.85%. Investors will be watching closely to see how the company's strategic initiatives and market performance evolve in the coming weeks.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
